Arash Arashkia

1.3k total citations
81 papers, 944 citations indexed

About

Arash Arashkia is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Arash Arashkia has authored 81 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 23 papers in Epidemiology and 22 papers in Genetics. Recurrent topics in Arash Arashkia's work include Virus-based gene therapy research (22 papers), Immunotherapy and Immune Responses (15 papers) and Viral gastroenteritis research and epidemiology (13 papers). Arash Arashkia is often cited by papers focused on Virus-based gene therapy research (22 papers), Immunotherapy and Immune Responses (15 papers) and Viral gastroenteritis research and epidemiology (13 papers). Arash Arashkia collaborates with scholars based in Iran, France and United States. Arash Arashkia's co-authors include Nasser Hashemi Goradel, Babak Negahdari, Kayhan Azadmanesh, Farzin Roohvand, Somayeh Jalilvand, Zabihollah Shoja, Sajjad Ghorghanlu, Zahra Sharifzadeh, Nasir Mohajel and Mohsen Abolhassani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Biotechnology and Scientific Reports.

In The Last Decade

Arash Arashkia

76 papers receiving 928 citations

Peers

Arash Arashkia
Bingfeng Liu China
Farida Shaheen United States
David Requena United States
Ramin S. Herati United States
Guigao Lin China
Lukkana Suksanpaisan United States
Maria Tagliamonte Italy
Bernadette Ferraro United States
Olga Latinovic United States
Michael Heike Germany
Bingfeng Liu China
Arash Arashkia
Citations per year, relative to Arash Arashkia Arash Arashkia (= 1×) peers Bingfeng Liu

Countries citing papers authored by Arash Arashkia

Since Specialization
Citations

This map shows the geographic impact of Arash Arashkia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arash Arashkia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arash Arashkia more than expected).

Fields of papers citing papers by Arash Arashkia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arash Arashkia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arash Arashkia. The network helps show where Arash Arashkia may publish in the future.

Co-authorship network of co-authors of Arash Arashkia

This figure shows the co-authorship network connecting the top 25 collaborators of Arash Arashkia. A scholar is included among the top collaborators of Arash Arashkia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arash Arashkia. Arash Arashkia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sharifzadeh, Zahra, et al.. (2024). Tuning spacer length improves the functionality of the nanobody-based VEGFR2 CAR T cell. BMC Biotechnology. 24(1). 1–1. 7 indexed citations
3.
4.
Arefian, Ehsan, et al.. (2023). Nona-Arginine Mediated Anti-E6 ShRNA Delivery Suppresses the Growth of Hela Cells in vitro. PubMed. 27(6). 349–356. 3 indexed citations
5.
6.
Jalilvand, Somayeh, Arash Arashkia, Mohammad Farahmand, et al.. (2022). Co-administration of rotavirus nanospheres VP6 and NSP4 proteins enhanced the anti-NSP4 humoral responses in immunized mice. Microbial Pathogenesis. 163. 105405–105405. 7 indexed citations
7.
Fathi‐karkan, Sonia, et al.. (2021). The evolving direct and indirect platforms for the detection of SARS-CoV-2. Journal of Virological Methods. 300. 114381–114381. 27 indexed citations
8.
9.
Mohajel, Nasir & Arash Arashkia. (2021). Ebola as a case study for the patent landscape of medical countermeasures for emerging infectious diseases. Nature Biotechnology. 39(7). 799–807. 2 indexed citations
10.
Shoja, Zabihollah, et al.. (2021). Lineage analysis of human papillomavirus type 39 in cervical samples of Iranian women. Virology Journal. 18(1). 152–152. 4 indexed citations
11.
12.
Goradel, Nasser Hashemi, Babak Negahdari, Sajjad Ghorghanlu, Samira Jahangiri, & Arash Arashkia. (2020). Strategies for enhancing intratumoral spread of oncolytic adenoviruses. Pharmacology & Therapeutics. 213. 107586–107586. 25 indexed citations
13.
Farahmand, Mohammad, et al.. (2020). Estimation of genetic variation in the Secretor and Lewis genes in Iranian hospitalized children. Transfusion Clinique et Biologique. 28(1). 11–15. 1 indexed citations
14.
Khosravi, Mohammad, Jean‐Paul Concordet, Johannes vom Berg, et al.. (2019). Expression analysis data of BCL11A and γ-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion. Data in Brief. 28. 104974–104974. 6 indexed citations
15.
Roohvand, Farzin, et al.. (2017). Preparation and in vivo anti-tumor evaluation of human papillomavirus E7 adjuvanted with Montanide ISA 266 as a vaccine candidate. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Arashkia, Arash, Somayeh Jalilvand, Sayed Mahdi Marashi, et al.. (2017). Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone. Viral Immunology. 31(3). 233–241. 13 indexed citations
17.
Abasi, Mozhgan, Parviz Fallah, Arash Arashkia, et al.. (2017). Differential Maturation of miR-17 ~ 92 Cluster Members in Human Cancer Cell Lines. Applied Biochemistry and Biotechnology. 182(4). 1540–1547. 19 indexed citations
18.
Sepehrizadeh, Zargham, Mehdi Mahdavi, Arash Arashkia, et al.. (2014). Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20 (CCL20) gene as immunoadjuvant. Molecular Biology Reports. 41(9). 5943–5952. 6 indexed citations
19.
Arashkia, Arash, et al.. (2011). Immunoinformatics modeling, construction of DNA plasmids Carrying CTL epitopes of hepatitis C virus and their preliminary immunological analysis. Iranian Journal of Medical Microbiology. 4(4). 30–40. 1 indexed citations
20.
Memarnejadian, Arash, Farzin Roohvand, Arash Arashkia, Sima Rafati, & Mohammad Ali Shokrgozar. (2009). Polytope DNA Vaccine Development Against Hepatitis C Virus: A Streamlined Approach from In Silico Design to In Vitro and Primary In Vivo Analyses in BALB/c Mice. Protein and Peptide Letters. 16(7). 842–850. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bingfeng Liu Breakdown of academic impact, for papers by Farida Shaheen Breakdown of academic impact, for papers by David Requena Breakdown of academic impact, for papers by Ramin S. Herati Breakdown of academic impact, for papers by Guigao Lin Breakdown of academic impact, for papers by Lukkana Suksanpaisan Breakdown of academic impact, for papers by Maria Tagliamonte Breakdown of academic impact, for papers by Bernadette Ferraro Breakdown of academic impact, for papers by Olga Latinovic Breakdown of academic impact, for papers by Michael Heike
Rankless by CCL
2026